文献速递乳房整形与再造

网状与非网状脱细胞真皮基质在即刻乳房重建中的对比研究

Comparative Study of Meshed and Nonmeshed Acellular Dermal Matrix in Immediate Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

回顾性单中心研究比较83例(115侧)使用2:1网状牛源脱细胞真皮基质(SurgiMend)行即刻乳房重建与既往111例(147侧)非网状对照数据。网状组主要血清肿、血肿和感染率均显著低于对照组,引流管拔除时间缩短,包膜挛缩和假体取出率相似。

要点

  • 网状脱细胞真皮基质可显著降低即刻乳房重建术后主要血清肿、血肿和感染发生率
  • 网状组引流管拔除时间较非网状组缩短
  • 两组包膜挛缩率和假体取出率相似,无显著差异

核心结论

  • 与未网状脱细胞真皮基质相比,网状脱细胞真皮基质可降低术后血清肿、血肿和感染发生率并缩短引流管拔除时间。

研究设计与样本

  • 回顾性单中心分析纳入83例成年女性(115侧乳房),行一期(84.3%)或二期(15.7%)即刻乳房重建并使用2:1网状牛源脱细胞真皮基质(SurgiMend)。
  • 对照组为既往发表的111例患者(147侧乳房),接受相同手术但使用非网状(打孔)脱细胞真皮基质。

主要发现

  • 网状组平均年龄48.3岁,平均体重指数23.6 kg/m,平均随访23.6个月。
  • 网状组轻微和严重并发症总发生率分别为16.5%和13.0%,与对照组(25.2%和12.9%)相似。
  • 网状组主要血清肿发生率0% vs 对照组8.2%(OR无穷大;95%CI 1.927至无穷大),总血肿发生率0% vs 4.8%(OR无穷大;95%CI 1.022至无穷大),总感染发生率10.4% vs 23.8%(OR 2.682;95%CI 1.259-5.802)。
  • 网状组引流管拔除时间缩短。
  • 网状组与对照组包膜挛缩率(5.2% vs 2.7%)和假体取出率(5.2% vs 2.7%)相似。

临床怎么用

  • 在即刻乳房重建中使用网状脱细胞真皮基质可能有助于减少血清肿、血肿和感染,并缩短引流时间。

局限性

  • 本研究为回顾性单中心分析,对照组数据来自既往发表资料而非同期随机对照。
  • 网状组化疗史患者少于对照组,可能影响基线可比性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acellular dermal matrices are commonly used to support implant-based breast reconstruction. Meshing may enhance integration, reduce drain time and seroma, and decrease surgical costs. METHODS: This was a retrospective, single-center analysis of 83 adult women (115 breasts) undergoing one-stage (84.3 percent) or two-stage (15.7 percent) immediate breast reconstruction with bovine-derived acellular dermal matrix (SurgiMend) meshed at a 2:1 ratio. Outcomes were compared with previously published data from a control group of 111 patients (147 breasts) undergoing the same procedure with nonmeshed (fenestrated) acellular dermal matrix. RESULTS: The mean age of patients receiving meshed acellular dermal matrix was 48.3 years and the mean body mass index was 23.6 kg/m. There were no significant differences in baseline characteristics versus controls, other than chemotherapy history (received by fewer patients in the meshed acellular dermal matrix group). Mean follow-up was 23.6 months. Overall rates of minor and major complications in the meshed acellular dermal matrix group were 16.5 percent and 13.0 percent, respectively-similar to controls (25.2 percent and 12.9 percent). However, with meshed acellular dermal matrix, there were significantly fewer major seromas (0 percent versus 8.2 percent; OR, ∞; 95 percent CI, 1.927 to ∞), fewer total hematomas (0 percent versus 4.8 percent; OR, ∞; 95 percent CI, 1.022 to ∞), and fewer total infections (10.4 percent versus 23.8 percent; OR, 2.682; 95 percent CI, 1.259 to 5.802) compared with controls. Time to drain removal was reduced. Rates of capsular contracture (5.2 percent versus 2.7 percent) and explantation (5.2 percent versus 2.7 percent) were similar in the meshed acellular dermal matrix and control groups. CONCLUSION: Acellular dermal matrix meshing reduces rates of postoperative seroma, hematoma, and infection and decreases drain removal time compared with nonmeshed acellular dermal matrix. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Maisel Lotan A, Ben Yehuda D, Allweis TM, et al. Comparative Study of Meshed and Nonmeshed Acellular Dermal Matrix in Immediate Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 31441807. doi:10.1097/PRS.0000000000006116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。